Genetic engineering of dendritic cells to enhance their tolerogenic potential

Graft

Volumn 5, Issue 5, 2002, Pages 308-314

  Lu, Lina ^a   Thomson, Angus W ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Dendritic cells; Gene therapy; Immunosuppression; Tolerance; Transplantation

Indexed keywords

ALLOANTIGEN; B7 ANTIGEN; CD134 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS LIGAND; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

ANTIGEN PRESENTING CELL; APOPTOSIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL TRANSFER; CLONAL ANERGY; CONTROLLED STUDY; DENDRITIC CELL; EXPERIMENTAL MODEL; GENETIC ENGINEERING; GRAFT REJECTION; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; REGULATORY MECHANISM; REVIEW; TH2 CELL; TRANSPLANTATION TOLERANCE;

EID: 0036345406     PISSN: 15221628     EISSN: None     Source Type: Journal    
DOI: 10.1177/1522162802005005006     Document Type: Review

References (46)

1. The dendritic cell system and its role in immunogenicity
2. Dendritic cells and the control of immunity
3. Microchimerism, dendritic cell progenitors and transplantation tolerance
4. Strategies to promote tolerance induction using dendritic cells
5. Studies of the role of the thymic environment in the induction of tolerance to MHC antigens
6. Does T-cell tolerance require a dedicated antigen-presenting cell?
7. Induction of peripheral tolerance by intrathymic inoculation of soluble alloantigens: Evidence for the role of host antigen-presenting cells and suppressor cell mechanism
8. Indirect allorecognition in acquired thymic tolerance: Induction of donor-specific tolerance to rat cardiac allografts by allopeptide-pulsed host dendritic cells
9. Major histocompatibility complex class I peptide-pulsed host dendritic cells induce antigen-specific acquired thymic tolerance to islet cells
10. + T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells
11. The induction of tolerance by dendritic cells that have captured apoptotic cells
12. Dendritic cell tolerogenicity and prospects for dendritic cell-based therapy of allograft rejection and autoimmune disease
13. Dendritic cells as regulators of immune reactivity: Implications for transplantation
14. Dendritic cell tolerogenicity and prospects for cell-based therapy of allograft rejection and autoimmunity
15. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation
16. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis
17. Different migration patterns of antigen-presenting cells correlate with Th1/Th2-type responses in mice
18. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells
19. Effect of interleukin-10 on dendritic cell maturation and function
20. Interleukin-13, in combination with anti-interleukin-12, increases graft prolongation after portal venous immunization with cultured allogeneic bone marrow-derived dendritic cells
21. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood
22. Liver-derived DEC205(+)B220(+)CD19(-) dendritic cells regulate T cell responses
23. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells
24. Designer dendritic cells for tolerance induction - Guided not misguided missiles
25. Dendritic cells genetically engineered to express Fas Ligand induce donor-specific hyporesponsiveness and prolong allograft survival
26. A dendritic cell line genetically modified to express CTLA4-Ig as a means to prolong islet allograft survival
27. Human myeloid dendritic cells transduced with an adenoviral interleukin-10 gene construct inhibit human skin graft rejection in humanized NOD-scid chimeric mice
28. Dendritic cell Th2 cytokine gene therapy in sheep
29. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance
30. Development of CD8alpha-positive dendritic cells from a common myeloid progenitor
31. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo
32. CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo
33. Dendritic cell development: Multiple pathways to nature's adjuvants
34. The evolution of self-tolerance: A new cell arises to meet the challenge of self-reactivity
35. CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells
36. Immature and mature CD8I+ dendritic cells prolong the survival of vascularized cardiac allografts
37. Dendritic cell lineage, plasticity and cross-regulation
38. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand
39. Reciprocal control of T helper cell and dendritic cell differentiation
40. The nature of the principal type 1 interferon-producing cells in human blood
41. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells
42. Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness
43. Transduction of dendritic cell progenitors with a retroviral vector encoding viral IL-10 and enhanced green fluorescent protein allows purification of potentially tolerogenic antigen-presenting cells
44. Synergy in induction of increased renal allograft survival after portal vein infusion of dendritic cells transduced to express TGFbeta and IL-10, along with administration of CHO cells expressing the regulatory molecule OX-2
45. Immunomodulation by dendritic cells transfected with CTLA4-Ig is enhanced by NF-kB decoy oligodeoxyribonucleotides
46. Donor-specific dendritic cells modulate cardiac allograft rejection